An alternative for consumers concerned about risks of inhaling cannabis and unpredictable, delayed intensity of edibles, Chill Pill™ offers precision dosing and superior bioavailability for fast, reliable effects.
PAYSON, Ariz. (May 19, 2023) – The Arizona cannabis marketplace is a nearly $1.4 billion dollar industry, and as cannabis consumption gains more mainstream acceptance, a growing number of health-conscious consumers are looking for an alternative way to enjoy the benefits of cannabis without the drawbacks of smoking.
The Arizona-based Chill PillTM brand, an expansive line of easy-to-swallow THC soft gels, is the latest solution for healthful consumers who are seeking alternative consumption methods that offer rapid uptake and controlled dosing without the risks associated with smoking and vaping, or the unpredictable intensity of sugary edibles that can take hours to work.
Available in a variety of strengths and strains, with effects ranging from highly responsive to highly relaxed, Chill Pill soft gels offer consumers better options to control onset timing, intensity and duration of desired effects. In addition, Chill Pill THC soft gels provide precise dosing, measured twice, once before encapsulation and once after the soft gel is created, resulting in higher quality, more consistent products.
“Consumers look to THC soft gels as a way to receive the many benefits of cannabis without the drawbacks that can often come with smoking,” said Francis Baczek, V.P of Business Development at Ally Biotech. “Chill Pill soft gels stand out against other edible consumption methods with their precision dosing and, for health-minded consumers conscious of their sugar intake, they are made without the added sugar often found in other edible products.”
Because of all of its benefits, the cannabis capsule marketplace is experiencing exponential growth and is expected to continue to grow an estimated 18 percent by 2027, according to Data Bridge Market Research.
The Chill Pill soft gels line offers a variety of formulations including:
- Day Caps – a CBG and sativa dominant formula.
- Anytime Caps – a hybrid formulation that combines sativa and indica.
- Night Caps – a CBN and indica dominant formula.
- Anytime Caps + CBD – a 1:1 blend of THC and CBD.
- THC-A – Non-intoxicating symptom relief with no psychoactive effects.
For more information about the Chill Pill, and to stay up to date with new innovations coming soon to a dispensary near you, visit ChillPillsAZ.com.
About Ally Biotech:
Headquartered in Payson, Arizona, Ally Biotech offers highly bioavailable products to leading manufacturers and dispensaries of cannabis products since 2018. The company recently acquired the Chill Pill line of products. The company’s Lipofusion® delivery technology combines nanotechnology and liposomal science to speed product differentiation and innovation. Ally Biotech offers product development services, and manufacturing-ready, water soluble Lipofusion THC that can be utilized as a raw ingredient in powder or liquid form in a variety of products. All of the company’s products undergo rigorous testing for purity, potency, safety and efficacy at third-party laboratories. For more information, visit AllyBiotech.com. For more information about the Chill Pill, visit ChillPillsAZ.com.
About Chill Pill:
The Arizona-based Chill PillTM brand is an expansive line of easy-to-swallow THC soft gels for the cannabis industry. Formulated using hemp seed oil, Chill Pills are easy to absorb, metabolize, and come in a variety of strengths and strains, with effects ranging from highly responsive to highly relaxed. Chill Pill is owned and operated by Ally Biotech, a company committed to harnessing the power of science to create innovative THC products, such as their patented Lipofusion® technology. For more information, visit ChillPillsAZ.com.
Media Contact:
Sadie Thompson
Proven Media
602-527-0794
sadie@provenmediaservices.com
